Leukemia Drug Ibrutinib Effective In Long-Term Study
"A lot of the patients from the initial phase II study have been on drug for two to three years," he added. "Long term follow
leukemia drug ibrutinib effective long term study lot patient initial phase ii study drug year add long term follow